Fox & Friends’ Wellness Week swung into the world of IV drips, peptides and creatine, sparking a debate over whether these treatments are clever health tools or inflated promises; the show demonstrated IV therapy and touted NAD and vitamins while a family medicine physician warned about overselling benefits and the risks of unregulated products.
The segment opened with “Fox & Friends” sending a host to try IV therapy, and the clinic framed the treatment as a way to counter stress and boost general wellness. The idea on offer was simple: a tailored IV cocktail could make you less likely to get sick and more ready to face the day. That promise landed well on camera, but it also raised questions in plain daylight about what the treatment actually delivers.
The IV drip given on screen included B vitamins, high-dose vitamin C, magnesium and amino acids, presented like a shortcut to feeling better fast. Clinics often package these mixtures as targeted solutions for fatigue, recovery and immunity. Still, mixing nutrients into a bag and pumping them into a vein is not the same thing as showing long-term benefit in large, randomized studies.
The crew also mentioned NAD, pitching it as a fix for mental fuzziness and physical recovery with lines like “is going to clear up any brain fog” and calling it “amazing for physical injury.” Those are bold statements, and anytime language edges toward miracle-sounding promises, it should trigger a closer look. Claims that sound absolute are where skepticism belongs, because human biology rarely cooperates with absolutes.
On camera, the clinician reassured the host, saying, “Honestly, there are no negative side effects,” and promising that users would “sleep really well, wake up really well-rested to your first alarm.” That kind of certainty comforts viewers, but it also flattens nuance about dosing, interactions and individual variation. What helps one person can be neutral or harmful to another, so blanket safety claims are risky ground.
Dr. Mike Varshavski, a family medicine physician, pushed back on the presentation, warning that the visit included too many promises and not enough informed consent. “It’s tough to say what actually happened in that visit because there were a lot of promises being made,” he said, underscoring that patients should know what to expect and what the science actually supports. His main image was practical: compare the body to a car’s fuel tank and you see why simply pouring extras in may cause overflow rather than better performance.
That analogy led him to another blunt line: “putting more and having it spill all over the place just creates added side effects.” He pointed out that piling on supplements isn’t harmless, noting that fat-soluble nutrients “can actually build up in your fat stores and create toxicities,” and flagged research tying very high levels of some B vitamins to increased cancer risk. Those are technical concerns that matter because they convert marketing language into real-world safety questions.
The conversation moved to performance aids like creatine and peptides. Varshavski acknowledged that creatine “actually has great evidence behind it” for boosting short, explosive movements while noting its overall contribution to fitness is modest. By contrast, he called unregulated injectable peptides “incredibly frightening,” warning that many products escape FDA oversight and slip into the market as research-only substances that can be contaminated or mislabelled.
Across the segment, the tension was clear: glossy clinic demos sell easy improvements, while physicians ask for data, clarity and honest consent. When it comes to supplements, injections and cutting-edge treatments, the safest path is clear-eyed skepticism and asking hard questions instead of buying into easy promises. As Varshavski summed it up plainly, “it’s not as simple as more equals better.”
